# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian epithelial cancer

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 61-70 of 535 results.
Pembrolizumab in Combination With Bevacizumab and Pegylated Liposomal Doxorubicin in Patients With Ovarian Cancer
Status: Not yet recruiting
Last Changed: Jul 23, 2018
First Received: Jul 23, 2018
Disease(s): Ovarian Cancer
Intervention(s): Pembrolizumab, Bevacizumab, pegylated liposomal doxorubicin (PLD)
Locations: Gustave Roussy, Villejuif, Val De Marne, France
Evaluation of Surgical Excision of Cardiophrenic Lymph Nodes in Patients With Advanced Ovarian Cancer
Status: Recruiting
Last Changed: Aug 01, 2017
First Received: Aug 01, 2017
Disease(s): Ovarian Cancer
Intervention(s): cardiophrenic lymph nodes resection
Locations: Oncology center, Mansoura University, Cairo, Dakhlia, Egypt
CB-839 in Combination With Niraparib in Platinum Resistant BRCA -Wild-type Ovarian Cancer Patients
Status: Not yet recruiting
Last Changed: Feb 28, 2020
First Received: May 10, 2019
Disease(s): Ovarian Cancer, Resistant BRCA Wild-Type Ovarian Cancer
Intervention(s): Cohort 1: Dose Escalation, Cohort 2: Dose Escalation
Locations: University of Alabama at Birmingham, Birmingham, Alabama, United States
Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer
Status: Recruiting
Last Changed: Nov 25, 2019
First Received: Nov 25, 2019
Disease(s): Ovarian Cancer Recurrent
Intervention(s): Bevacizumab, Tocotrienol
Locations: Department of Oncology, Vejle Hospital, Vejle, Denmark
Efficacy and Safety of Paclitaxel for Injection (Albumin-bound) for First-line Chemotherapy of Ovarian Cancer
Status: Not yet recruiting
Last Changed: Feb 26, 2019
First Received: Jan 28, 2019
Disease(s): Ovarian Cancer
Intervention(s): Paclitaxel for injection (albumin-bound)
Vitamin D, Leptin, Vitamin D Receptor Polymorphism, and Treatment-Related Morbidity in Ovarian Cancer
Status: Recruiting
Last Changed: Mar 06, 2020
First Received: Jan 23, 2017
Disease(s): Ovarian Cancer
Intervention(s): Vitamin D3
Locations: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125
Status: Recruiting
Last Changed: Oct 01, 2019
First Received: Dec 28, 2016
Disease(s): Ovarian Cancer
Locations: Department of Oncology, Vejle Hospital, Vejle, Denmark
A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.
Status: Recruiting
Last Changed: Mar 16, 2020
First Received: Apr 11, 2017
Disease(s): Epithelial Ovarian Cancer
Intervention(s): Active Comparator: Olaparib tablets, Placebo
Locations: Research Site, Brussels, Belgium
Research Site, Leuven, Belgium
Research Site, Liège, Belgium
Research Site, Namur, Belgium
Research Site, London, Ontario, Canada
... and 101 other locations.
Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire
Status: Recruiting
Last Changed: Aug 03, 2018
First Received: Aug 03, 2018
Disease(s): Ovarian Cancer
Locations: Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China
Sichuan Cancer Hospital, Chengdu, Sichuan, China
Affiliated Cancer Hospital of Xinjiang Medical University, Ürümqi, Xinjiang, China
Peking Union Medical College Hospital, Beijing, China
... and 2 other locations.
OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer
Status: Recruiting
Last Changed: Aug 29, 2019
First Received: Jun 08, 2017
Disease(s): Ovarian Cancer
Intervention(s): OTL38, near infrared imaging
Locations: The Mayo Clinic - Phoenix, Phoenix, Arizona, United States
University of Arizona, Tucson, Arizona, United States
City of Hope Medical Center, Duarte, California, United States
University of CA at Irvine Chao Cancer Center, Orange, California, United States
Moffitt Cancer Center, Tampa, Florida, United States
... and 8 other locations.